A retrospective analysis on optimal medical therapy for patients with symptomatic lower extremity peripheral artery

Camille de Kermenguy1,2, Anne Durand1,2, Quentin Tollenaere1,2

  • 1Vascular Medicine Unit, CHU Rennes, 2 Rue Henri Le Guilloux, Rennes, 35033, France.

PubMed

Insights

Most lower extremity artery disease (LEAD) patients do not achieve LDL-cholesterol (LDLc) goals, with suboptimal medical treatment prevalence. Patients with a history of vascular surgery showed no improved management despite consistent follow-up.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Pharmacology

Background:

  • Symptomatic lower extremity artery disease (LEAD) management requires optimal lipid control (LDL-cholesterol [LDLc]) and medical therapy.
  • The prevalence of LEAD patients achieving LDLc < 0.55 g/L and optimal medical treatment is not well-established.
  • Optimal medical treatment includes triple therapy: antiplatelet, statin, and ACE inhibitor/ARB.

Purpose of the Study:

  • To determine the prevalence of LEAD patients achieving LDLc < 0.55 g/L.
  • To assess the prevalence of optimal medical treatment in LEAD patients.
  • To compare management strategies between LEAD patients with and without a history of vascular surgery.
  • To evaluate eligibility for novel lipid-lowering therapies (FOURIER and REDUCE-IT criteria).

Main Methods:

  • Single-center retrospective study design.
  • Prevalence calculated using numbers and percentages.
  • Comparison of management between LEAD patients with and without prior vascular surgery.
  • Calculation of patient eligibility for FOURIER (evolocumab) and REDUCE-IT (icosapent ethyl) studies.

Main Results:

  • Only 12.4% of LEAD patients achieved LDLc < 0.55 g/L.
  • Optimal medical treatment was received by 50.7% of patients.
  • No significant difference in LDLc goal achievement between patients with (10.6%) and without (13.6%) vascular surgery history.
  • 46.0% of patients were eligible for evolocumab and 8.4% for icosapent ethyl.

Conclusions:

  • A significant majority of lower extremity artery disease patients do not meet LDL-cholesterol goals.
  • LEAD patients with a history of vascular surgery did not demonstrate superior management outcomes.
  • Despite more consistent follow-up, vascular surgery history did not correlate with better medical management in LEAD patients.
Abstract

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...